Baird Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $568

Benzinga · 3d ago
Baird analyst Joel Beatty maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $514 to $568.